Safety, tolerance, and pharmacokinetics of atevirdine mesylate (U-87201E) in asymptomatic human immunodeficiency virus-infected patients.

Atevirdine mesylate (U-87201E) is a new nonnucleoside (bisheteroarylpiperazine) inhibitor of human immunodeficiency virus type 1 reverse transcriptase. In a double-blind, escalating single-dose study the safety, tolerance, and pharmacokinetics of atevirdine mesylate were investigated in 24 asymptoma...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Antimicrob Agents Chemother
Päätekijät:	Been-Tiktak, A M, Vrehen, H M, Schneider, M M, van der Feltz, M, Branger, T, Ward, P, Cox, S R, Harry, J D, Borleffs, J C
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 1995
Aiheet:	Research Article
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162591/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7793859/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.39.3.602
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!